EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Network pharmacology and experiments verify the effect of triptolide on extraocular muscle fibrosis

Minmin Jiang, Ping Wang, Dandan Yu, Panpan Guo, Zhiyu Qu, Jingxiao Zhao, Shuxun Yan iD

PLOS One · 2025

DOI: 10.1371/journal.pone.0336487 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS One, 2025. Verfasst von Minmin Jiang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology, The First Affiliated Hospital of Henan University of Chinese Medicine, Zhengzhou, Henan Province, China. Hauptthemen laut MEDLINE: Diterpenes, Phenanthrenes, Network Pharmacology, Oculomotor Muscles. Die Arbeit nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Henan Province Traditional Chinese Medicine Inheritance and Innovation Talent Project, Henan Province Traditional Chinese Medicine Research Special Project, Zhengzhou City Collaborative Innovation Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Drugs usually do not prevent extraocular muscle fibrosis in Graves’ ophthalmopathy (GO), and surgical treatment has complications and does not cure extraocular muscle fibrosis. Triptolide (TPL) has shown antifibrotic effects; however, the mechanism by which it treats extraocular muscle fibrosis in GO remains unclear. The aim of this study was to investigate the therapeutic effect and potential mechanism of TPL through a combination of network pharmacology and experimental validation. Network pharmacology identified 10 potential therapeutic targets, 1767 gene ontology terms, and 95 signaling pathways, including the PI3K/AKT pathway. Molecular docking revealed a strong affinity between core targets on the PI3K/AKT pathway and TPL. The experimental results showed that TPL inhibited the proliferation of OFs in vitro in a concentration-dependent manner. It significantly inhibited the expression of TGF-β1-induced fibrosis-related markers, such as FN, CTGF, α-SMA, and TIMP-1, while significantly down-regulating the expression of PI3K/AKT signaling proteins. The use of inhibitors of the PI3K/AKT pathway inhibited the expression of fibrosis-related markers. These findings suggest that TPL can resist extraocular muscle fibrosis in GO through multiple pathways, in which the PI3K/AKT pathway plays a key role.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DiterpenesPhenanthrenesNetwork PharmacologyOculomotor MusclesGraves OphthalmopathyEpoxy CompoundsFibrosisSignal TransductionProto-Oncogene Proteins c-aktHumansPhosphatidylinositol 3-KinasesCell ProliferationMolecular Docking SimulationTransforming Growth Factor beta1

Substanzen

triptolideDiterpenesPhenanthrenesEpoxy CompoundsProto-Oncogene Proteins c-aktPhosphatidylinositol 3-KinasesTransforming Growth Factor beta1

Autor:innen und Institutionen

  • Department of Endocrinology, The First Affiliated Hospital of Henan University of Chinese Medicine, Zhengzhou, Henan Province, China.

ORCID-Profile: Shuxun Yan

Förderung

  • Henan Province Traditional Chinese Medicine Inheritance and Innovation Talent Project
  • Henan Province Traditional Chinese Medicine Research Special Project
  • Zhengzhou City Collaborative Innovation Project
  • Henan University of Traditional Chinese Medicine 2022 Postgraduate Research Innovation Ability Improvement Plan

Zitieren

APA

Jiang, M., Wang, P., Yu, D., Guo, P., Qu, Z., Zhao, J., & Yan, S. (2025). Network pharmacology and experiments verify the effect of triptolide on extraocular muscle fibrosis. PLOS One. https://doi.org/10.1371/journal.pone.0336487

Vancouver

Jiang M, Wang P, Yu D, Guo P, Qu Z, Zhao J, et al. Network pharmacology and experiments verify the effect of triptolide on extraocular muscle fibrosis. PLOS One. 2025. doi:10.1371/journal.pone.0336487

BibTeX
@article{Jiang2025,
  author = {Jiang, Minmin and Wang, Ping and Yu, Dandan and Guo, Panpan and Qu, Zhiyu and Zhao, Jingxiao and Yan, Shuxun},
  title = {Network pharmacology and experiments verify the effect of triptolide on extraocular muscle fibrosis},
  journal = {PLOS One},
  year = {2025},
  doi = {10.1371/journal.pone.0336487}
}
Kostenlos starten →